Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 28, Issue 3, Pages 545-556
Publisher
Springer Science and Business Media LLC
Online
2022-03-01
DOI
10.1038/s41591-022-01698-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unraveling city-specific signature and identifying sample origin locations for the data from CAMDA MetaSUB challenge
- (2021) Runzhi Zhang et al. Biology Direct
- Infection trains the host for microbiota-enhanced resistance to pathogens
- (2021) Apollo Stacy et al. CELL
- Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals
- (2021) Francesco Asnicar et al. NATURE MEDICINE
- A uniform computational approach improved on existing pipelines to reveal microbiome biomarkers of non-response to immune checkpoint inhibitors
- (2021) Fyza Y Shaikh et al. CLINICAL CANCER RESEARCH
- Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
- (2021) Diwakar Davar et al. SCIENCE
- Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
- (2021) Cristina Valero et al. Nature Communications
- Ethnicity influences the gut microbiota of individuals sharing a geographical location: a cross-sectional study from a middle-income country
- (2021) Jacky Dwiyanto et al. Scientific Reports
- Anti‐PD1‐Induced Immune‐Related Adverse Events and Survival Outcomes in Advanced Melanoma
- (2020) Aleksi Suo et al. ONCOLOGIST
- Immune‐Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration‐Approved Indications for Immunotherapy
- (2020) Satya Das et al. ONCOLOGIST
- Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
- (2020) Lisa Derosa et al. EUROPEAN UROLOGY
- Dendritic cell–derived hepcidin sequesters iron from the microbiota to promote mucosal healing
- (2020) Nicholas J. Bessman et al. SCIENCE
- Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody
- (2020) Hiroshi Matsuoka et al. BMC CANCER
- The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
- (2020) Ai-Ping Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Gut microbiota composition is associated with newborn functional brain connectivity and behavioral temperament
- (2020) Caroline M. Kelsey et al. BRAIN BEHAVIOR AND IMMUNITY
- Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
- (2020) Erez N. Baruch et al. SCIENCE
- Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma
- (2020) Angelo Limeta et al. JCI Insight
- Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
- (2020) Caroline Robert et al. EUROPEAN JOURNAL OF CANCER
- Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
- (2019) Paolo A. Ascierto et al. Journal for ImmunoTherapy of Cancer
- MetaBAT 2: an adaptive binning algorithm for robust and efficient genome reconstruction from metagenome assemblies
- (2019) Dongwan D. Kang et al. PeerJ
- Evaluate Cutpoints: Adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator
- (2019) Magdalena Ogłuszka et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
- (2019) Angela Horvath et al. Scientific Reports
- Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
- (2019) Brandilyn A. Peters et al. Genome Medicine
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
- (2018) Koji Haratani et al. JAMA Oncology
- Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
- (2018) Mariaelena Capone et al. Journal for ImmunoTherapy of Cancer
- American Gut: an Open Platform for Citizen Science Microbiome Research
- (2018) Daniel McDonald et al. mSystems
- Regional variation limits applications of healthy gut microbiome reference ranges and disease models
- (2018) Yan He et al. NATURE MEDICINE
- Microbiota and cancer immunotherapy: in search of microbial signals
- (2018) Raad Z Gharaibeh et al. GUT
- Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma
- (2018) Diwakar Davar et al. JOURNAL OF CLINICAL ONCOLOGY
- Gut microbiota diversity across ethnicities in the United States
- (2018) Andrew W. Brooks et al. PLOS BIOLOGY
- Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
- (2017) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- The non-invasive exfoliated transcriptome (exfoliome) reflects the tissue-level transcriptome in a mouse model of NSAID enteropathy
- (2017) Canaan M. Whitfield-Cargile et al. Scientific Reports
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Enterotypes in the landscape of gut microbial community composition
- (2017) Paul I. Costea et al. Nature Microbiology
- Correcting for Microbial Blooms in Fecal Samples during Room-Temperature Shipping
- (2017) Amnon Amir et al. mSystems
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- Unexpected links reflect the noise in networks
- (2016) Anatoly Yambartsev et al. Biology Direct
- MEGAHIT v1.0: A fast and scalable metagenome assembler driven by advanced methodologies and community practices
- (2016) Dinghua Li et al. METHODS
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle
- (2016) Anastassia Gorvitovskaia et al. Microbiome
- MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph
- (2015) Dinghua Li et al. BIOINFORMATICS
- Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
- (2015) Jacob H. Levine et al. CELL
- Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes
- (2015) M. Freeman-Keller et al. CLINICAL CANCER RESEARCH
- Cloning, characterization, and production of three α-l-fucosidases fromClostridium perfringensATCC 13124
- (2015) Shuquan Fan et al. JOURNAL OF BASIC MICROBIOLOGY
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- MetaBAT, an efficient tool for accurately reconstructing single genomes from complex microbial communities
- (2015) Dongwan D. Kang et al. PeerJ
- Prokka: rapid prokaryotic genome annotation
- (2014) T. Seemann BIOINFORMATICS
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Rethinking “Enterotypes”
- (2014) Dan Knights et al. Cell Host & Microbe
- The role of the microbiota in inflammation, carcinogenesis, and cancer therapy
- (2014) Amiran Dzutsev et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Non-invasive analysis of intestinal development in preterm and term infants using RNA-Sequencing
- (2014) Jason M. Knight et al. Scientific Reports
- Distinct functions of polysaccharide deacetylases in cell shape, neutral polysaccharide synthesis and virulence ofBacillus anthracis
- (2013) Stavroula Balomenou et al. MOLECULAR MICROBIOLOGY
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Batch effect removal methods for microarray gene expression data integration: a survey
- (2012) C. Lazar et al. BRIEFINGS IN BIOINFORMATICS
- Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
- (2012) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- A framework for human microbiome research
- (2012) NATURE
- MR1 presents microbial vitamin B metabolites to MAIT cells
- (2012) Lars Kjer-Nielsen et al. NATURE
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- The Human Microbiome Project: A Community Resource for the Healthy Human Microbiome
- (2012) Dirk Gevers et al. PLOS BIOLOGY
- Enterotypes of the human gut microbiome
- (2011) Manimozhiyan Arumugam et al. NATURE
- Metagenomic biomarker discovery and explanation
- (2011) Nicola Segata et al. GENOME BIOLOGY
- Identification and Characterization of a Glycosyltransferase Involved in Acinetobacter baumannii Lipopolysaccharide Core Biosynthesis
- (2010) N. R. Luke et al. INFECTION AND IMMUNITY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started